AQP4 and neuromyelitis optica: Recently recognized as a distinct clinical entity from Multiple Sclerosis (MS)[1], NMO patients show B cell autoimmunity; while NMO-IgG, an antibody that targets aquaporin-4, was found in the serum of 70% of the patients [2].